Geode Capital Management’s Five Prime Therapeutics, Inc. FPRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
|
|||||
|
2021
Q1 | $25.2M | Buy |
|
|||||
|
2020
Q4 | $10.7M | Buy |
|
|||||
|
2020
Q3 | $2.54M | Buy |
|
|||||
|
2020
Q2 | $3.03M | Sell |
|
|||||
|
2020
Q1 | $1.22M | Buy |
|
|||||
|
2019
Q4 | $2.37M | Buy |
|
|||||
|
2019
Q3 | $1.8M | Buy |
|
|||||
|
2019
Q2 | $2.71M | Buy |
|
|||||
|
2019
Q1 | $5.74M | Buy |
|
|||||
|
2018
Q4 | $3.81M | Buy |
|
|||||
|
2018
Q3 | $5.17M | Buy |
|
|||||
|
2018
Q2 | $5.76M | Buy |
|
|||||
|
2018
Q1 | $5.66M | Buy |
|
|||||
|
2017
Q4 | $5.73M | Buy |
|
|||||
|
2017
Q3 | $10.6M | Buy |
|
|||||
|
2017
Q2 | $7.29M | Buy |
|
|||||
|
2017
Q1 | $8.66M | Sell |
|
|||||
|
2016
Q4 | $12.5M | Buy |
|
|||||
|
2016
Q3 | $12.8M | Buy |
|
|||||
|
2016
Q2 | $9.18M | Buy |
|
|||||
|
2016
Q1 | $7.65K | Buy |
|
|||||
|
2015
Q4 | $7.62M | Buy |
|
|||||
|
2015
Q3 | $2.11M | Buy |
|
|||||
|
2015
Q2 | $3.22M | Sell |
|
|||||
|
2015
Q1 | $3.23M | Buy |
|
|||||
|
2014
Q4 | $1.93M | Buy |
|
|||||
|
2014
Q3 | $624K | Sell |
|
|||||
|
2014
Q2 | $828K | Buy |
|
|||||
|
2014
Q1 | $893K | Buy |
|
|||||
|
2013
Q4 | $496K | Buy |
|